Lotus Eye Hospital And Institute Ltd stock analysis
Want to see IN:LOTUSEYE full AI Analyst Report?
Lotus Eye Hospital And Institute Ltd (LOTUSEYE) Stock Price & Analysis
LOTUSEYE Stock Chart & Stats
- Day’s Range
- INR 100.70 - INR 104.05
- 52-Week Range
- INR 97.60 - INR 153.00
- Previous Close
- INR 103.65
- Volume
- N/A
- Average Volume (3M)
- 2,846
- Market Cap
- INR 2.16B
- Enterprise Value
- INR 2.69B
- Total Cash (Recent Filing)
- INR 38.27M
- Total Debt (Recent Filing)
- INR 0
- Price to Earnings (P/E)
- 439.7
- Beta
- 0.54
- Next Earnings
- Feb 15, 2027 (Est.)
- EPS Estimate
- N/A
- Last Dividend Ex-Date
- Sep 18, 2023
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Steady Revenue Growth
Continued revenue expansion indicates that Lotus Eye Hospital is maintaining demand for its ophthalmology-focused consultations, diagnostics, procedures, and clinical services. Sustained top-line growth provides a foundation for future operating improvement if the company can convert additional volume into healthier margins.
Equity Support
The company retains a sizeable equity base relative to its reported debt, providing some balance-sheet support while it works to restore profitability. This capital cushion can improve resilience and preserve strategic flexibility, although the benefit is tempered by the recent increase in leverage.
Positive Operating Cash Flow
Positive operating cash flow shows that the core business is still generating cash from operations despite very low reported earnings. Although the amount has declined from prior peaks, this underlying cash contribution offers some internal funding capacity and supports ongoing clinical operations.
Bears Say
Severe Margin Deterioration
Sharp deterioration in both net and operating margins means revenue growth is currently producing little or no operating profit. Persistently weak profitability would reduce reinvestment capacity, make earnings more vulnerable to cost pressure, and limit the financial benefits of further volume growth.
Rapidly Rising Leverage
The rapid increase in debt relative to equity raises financial risk while earnings are under pressure. Higher leverage can increase fixed funding obligations and reduce flexibility to absorb continued margin weakness, particularly if the company needs additional capital to support expansion or operations.
Deeply Negative Free Cash Flow
Deeply negative free cash flow indicates that internally generated cash is not covering the company’s reinvestment and working-capital requirements. Combined with low net income and rising debt, this may create ongoing funding needs and reduce the quality and durability of cash generation.
Lotus Eye Hospital And Institute Ltd News
LOTUSEYE FAQ
What was Lotus Eye Hospital And Institute Ltd’s price range in the past 12 months?
What is Lotus Eye Hospital And Institute Ltd’s market cap?
When is Lotus Eye Hospital And Institute Ltd’s upcoming earnings report date?
How were Lotus Eye Hospital And Institute Ltd’s earnings last quarter?
Is Lotus Eye Hospital And Institute Ltd overvalued?
Does Lotus Eye Hospital And Institute Ltd pay dividends?
What is Lotus Eye Hospital And Institute Ltd’s EPS estimate?
How many shares outstanding does Lotus Eye Hospital And Institute Ltd have?
What happened to Lotus Eye Hospital And Institute Ltd’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Lotus Eye Hospital And Institute Ltd?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Lotus Eye Hospital And Institute Ltd
Lotus Eye Hospital and Institute Limited, a specialty eye care hospital, provides eye care and related services in India. The company offers ReLEx SMILE, a refractive lenticule extraction small incision lenticule extraction; touch free laser; lasik eye surgery; Epi-LASIK, an epithelial laser in situ keratomileusis; Intralase, a blade-free technique to create the corneal flap; Zyoptix Supracor laser technology; robotic femto laser cataract surgery; phacoemulsification; paediatric eye care and squint surgery; and micro incision cataract surgery treatments. It provides treatment services for various eye problems, such as refractive, cataract, glaucoma, retinal disease/diabetic eye care, neuro ophthalmology, binocular vision, and cornea infections, as well as various eye related courses. The company was formerly known as Lotus Eye Care Hospital Limited and changed its name to Lotus Eye Hospital and Institute Limited in April 2013. Lotus Eye Hospital and Institute Limited was founded in 1989 and is based in Coimbatore, India.
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- CEO
- S. K. Sundaramoorthy
- Employees
- 402
- Website
- www.lotuseye.org
- Address
- SF No. 770/12, Avinashi Road, Coimbatore, TN, 641014, IN
Lotus Eye Hospital And Institute Ltd (LOTUSEYE) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 5 | 4 | 13 |
| Technical Analysis | 4 | 4 | 2 |
| Moving Averages | 1 | 0 | 11 |
Similar Stocks
| Company | Price & Change | Follow |
|---|---|---|
| IN:APOLLOHOSPApollo Hospitals Enterprise Limited | ||
| IN:ASTERDMAster DM Healthcare Ltd. | ||
| IN:FORTISFortis Healthcare Ltd. | ||
| IN:MAXHEALTHMax Healthcare Institute Ltd | ||
| IN:MEDANTAGlobal Health Limited |




